Touchstone are allowed to manufacture cfoam for the sole purpose of research and development and cfoam gets the rights to use any technology or patents that are developed...
Just like having your own private research lab without the cost but with all the benefits...nice
Assets
As well as plant and equipment, the company owns 27 patents covering CFOAM’s manufacturing process and end use applications. Additionally, CFO own 3 registered trademarks in the US, and 5 domain names.
A licensing agreement permits Touchstone to manufacture CFOAM for the sole purpose of R&D, with CFO having rights to use any technology or patents that are developed.
Last edited by Max123:
Sorry.. From IPO documnet10/02/17
CFO Price at posting:
49.0¢ Sentiment: Buy Disclosure: Held
